Hostname: page-component-8448b6f56d-tj2md Total loading time: 0 Render date: 2024-04-19T06:28:11.469Z Has data issue: false hasContentIssue false
  • English
  • Français

Caffeine use by psychiatric patients

Published online by Cambridge University Press:  13 June 2014

J. Thomas Dalby  and
Richard Williams
J. Thomas Dalby
Affiliation:
Calgary General Hospital, 841 Centre Avenue East, Calgary, Alberta, Canada T2E 0A1 and Adjunct Associate Professor (Psychology) Adjunct Assistant Professor (Psychiatry), University of Calgary
Richard Williams
Affiliation:
Psychiatric Day Hospital, Calgary General Hospital and Associate Professor (Psychiatry), University of Calgary
Get access Rights & Permissions [Opens in a new window]

Abstract

Caffeine remains the most widely used psychoactive drug and psychiatric populations tend to ingest more caffeine than the general community. It is important to assess caffeine intake in psychiatric patients as it may distort diagnostic signs and is known to interact with psychotropic medications. A blanket condemnation of caffeine use by psychiatric patients is, however, unwarrranted for while it may exacerbate some conditions (eg. anxiety disorders) it may prove beneficial to others (eg. schizophrenics) when used in moderate quantities. A scale for the estimation of caffeine intake is provided.

Keywords

Caffeinepsychiatric patientsstimulantsanxietyself-treatmentrating scalewithdrawal symptoms
Type
Perspectives
Information
Irish Journal of Psychological Medicine , Volume 6 , Issue 2 , September 1989 , pp. 103 - 105
Copyright
Copyright © Cambridge University Press 1989

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.International Coffee Organization. United States of America coffee drinking study, winter 1988. London, England, 1988.Google Scholar
2.Gilbert, R M. Caffeine consumption. In: Spiller, G A, ed. The Methylxanthine Beverages and Foods: Chemistry, Consumption and Health Effects. New York: Liss, 1984.Google Scholar
3.Curatolo, P W, Robertson, D. The health consequences of caffeine. Ann Intern Med, 1983; 98: 641–653.CrossRefGoogle ScholarPubMed
4.Lieberman, H R, Wurtman, R J, Emde, G G, Coviella, I L G. The effects of caffeine and aspirin on mood and performance. Journal of Clinical Psychopharmacology, 1987; 7: 315–320.CrossRefGoogle ScholarPubMed
5.Greden, J F. Anxiety of caffeinism: A diagnostic dilemma. Am J Psychiatry, 1974; 131: 1089–1092.Google ScholarPubMed
6.Greden, J F, Fontaine, P, Lubetsky, M, Chamberlin, K. Anxiety and depression associated with caffeinism among psychiatric inpatients. Am J Psychiatry, 1978; 135: 963–966.Google ScholarPubMed
7.Victor, B S, Lubetsky, M, Greden, J F. Somatic manifestations of caffeinism. Journal of Clinical Psychiatry, 1981; 42: 185–188.Google ScholarPubMed
8.Gilliland, K, Andress, D. Ad lib caffeine consumption, symptoms of caffeinism, and academic performance. Am J Psychiatry, 1981;138: 512–514.Google ScholarPubMed
9.American Psychiatric Association. Diagnostic and statistical manual of mental disorders, Third edition - revised. American Psychiatric Association, Washington, D.C., 1987.Google Scholar
10.Clements, G L, Dailey, J W. Psychotropic effects of caffeine. Am Fam Physician, 1988; 37: 167–172.Google Scholar
11.Furlong, F W. Possible psychiatric significance of excessive coffee consumption. Canadian Psychiatric Association Journal, 1975; 20: 577–583.CrossRefGoogle ScholarPubMed
12.Winstead, D K. Coffee consumption among psychiatric impatients. Am J Psychiatry, 1976; 133: 1447–1450.Google Scholar
13.De Freitas, B, Schwartz, G. effects of caffeine in chronic psychiatric patients. Am J Psychiatry, 1979; 136: 1337–1338.Google ScholarPubMed
14.Rippere, V. Coffee and tea in psychiatric hospitals. The Lancet 1981; 07 4: 48.Google Scholar
15.Bezchlibnyk, K Z, Jeffries, J J. Should psychiatric patients drink coffee? Can Med Assoc J, 1981; 124: 357–358.Google ScholarPubMed
16.Pilette, W L. Caffeine: Psychiatric grounds for concern. Journal of Psychiatric Nursing and Mental Health Services, 1983; 21: 19–24.CrossRefGoogle ScholarPubMed
17.McManamy, M C, Schube, P G. Caffeine intoxication: Report of a case the symptoms of which amounted to a psychosis. N Eng J Med, 1936; 215: 616–620.CrossRefGoogle Scholar
18.Gilbert, R M, Marshman, J A, Schwieder, M, Berg, R. Caffeine content of beverages as consumed. Can Med Assoc J, 1976; 114: 205–208.Google ScholarPubMed
19.Bunker, M L, McWilliams, M. Caffeine content of common beverages. Journal of the American Dietetic Association, 1979; 74: 28–32.CrossRefGoogle ScholarPubMed
20.Stephenson, P E. Physiologic and psychotropic effects of caffeine on man. Journal of the American Dietetic Association, 1977; 71: 240–247.CrossRefGoogle ScholarPubMed
21.Ghoneim, M M, Hinrichs, J V, Chiang, C K, Loke, W H. Pharmacokinetic and pharmacodynamic interactions between caffeine and diazepam. Journal of Clinical Psychopharmacology, 1986; 6: 75–80.CrossRefGoogle ScholarPubMed
22.Mikkelson E., J. Caffeine and Schizophrenia. Journal of Clinical Psychiatry, 1978; 39: 732–734.Google Scholar
23.Chiarello, R J, Cole, J O. The use of psychostimulants in general psychiatry. A reconsideraton. Arch Gen Psychiatry, 1987; 44: 286–295.CrossRefGoogle Scholar
24.Schneier, F R, Siris, S G. A review of psychoactive substance use and abuse in schizophrenia: Patterns of drug choice. Journal of Nervous and Mental Disease, 1987; 175: 641–652.CrossRefGoogle ScholarPubMed
25.Prosser, R A, Pickens, R. Catecholamines, drug abuse and schizophrenia. In: Pickens, R W, Heston, L L, eds. Psychiatric Factors in Drug Abuse. New York: Grune & Stratton, 1979.Google Scholar
26.Neil, J F, Himmelhock, J M. Caffeinism complicating hypersomnic depressive episodes. Comprehensive Psychiatry, 1978; 19: 377–385.CrossRefGoogle ScholarPubMed
27.Gibson, C J. Caffeine withdrawal elevates urinary MHPG excretion. New Eng J Med, 1981; 304: 363.Google ScholarPubMed
28.Lee, M A, Flegel, P, Camerson, O, Greden, J F. Chronic caffeine consumption and the dexamethasone suppression test in depression. Psychiatry Research, 1988; 24: 61–65.CrossRefGoogle ScholarPubMed
29.Gelenberg A, J. (Ed) Factors influencing serum lithium levels. Massachusetts General Hospital Newsletter: Biological Therapies in Psychiatry, 1978; 1: 31–32.Google Scholar
30.Kingdon, . Effects of tea and coffee drinking. Lancet, 1833. 11: 47–48.Google Scholar
31.Griffiths, R R, Woodson, P P. Cafeine physical dependence: A review of human and laboratory animal studies. Psychopharmacology, 1988; 94: 437–451.CrossRefGoogle Scholar
32.Greden, J F, Domino, L. Headache. New Eng J Med, 1980; 303: 221.Google ScholarPubMed
33.Roller, L. Caffeinism: Subjective quantitative aspect of withdrawal syndrome. Med J Aust, 1981; 02: 146.Google Scholar
34.Edelstein, B A, Keaton-Brasted, C, Burg, M M. Effects of caffeine withdrawal and nocturnal enuresis, insomnia and behavior restraints. Journal of Consulting and Clinical Psychology, 1984; 52: 857–862.CrossRefGoogle ScholarPubMed
35.Foxx, R M, Rubinoff, A. Behavioral treatment of caffeinism: Reducing excessive coffee drinking. Journal of Applied Behavior Analysis, 1979; 12: 335–344.CrossRefGoogle ScholarPubMed
36.Ross, D M. Ross, S A. Hyperactivity: Current Isues, Research and Theory. New York:, 1982.Google Scholar
37.Dalby, J T. Will population decreases in caffeine consumption unveil attention deficit disorders in adults? Medical Hypotheses, 1985; 18: 163–167.CrossRefGoogle ScholarPubMed